EXT2 anticorps (AA 180-267) (FITC)

N° du produit ABIN7152311

Cet anticorps Lapin Polyclonal détecte spécifiquement EXT2 dans . Il présente une réactivité envers Humain.

Aperçu rapide pour EXT2 anticorps (AA 180-267) (FITC) (ABIN7152311)

Antigène: EXT2 (Exostosin 2 (EXT2))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp EXT2 est conjugé à/à la FITC

Application: Veuillez nous consulter SVP

Détail du produit anti-EXT2 anticorps (FITC)

Épitope: AA 180-267

Réactivité croisée: Humain

Purification: >95%, Protein G purified

Immunogène: Recombinant Human Exostosin-2 protein (180-267AA)

Isotype: IgG

Information d'application

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,-80 °C

Stockage commentaire: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Détails sur EXT2

Antigène: EXT2 (Exostosin 2 (EXT2))

Autre désignation: EXT2

Sujet:

Background: Glycosyltransferase required for the biosynthesis of heparan-sulfate. The EXT1/EXT2 complex possesses substantially higher glycosyltransferase activity than EXT1 or EXT2 alone. Appears to be a tumor suppressor. Required for the exosomal release of SDCBP, CD63 and syndecan (PubMed:22660413).

Aliases: Exostoses (multiple) 2 antibody, Exostosin 2 antibody, Exostosin-2 antibody, EXT2 antibody, EXT2_HUMAN antibody, Glucuronosyl N acetylglucosaminyl proteoglycan 4 alpha N acetylglucosaminyltransferase antibody, Glucuronosyl-N-acetylglucosaminyl-proteoglycan/N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase antibody, Multiple exostoses protein 2 antibody, N acetylglucosaminyl proteoglycan 4 beta glucuronosyltransferase antibody, Putative tumor suppressor protein EXT2 antibody, SOTV antibody

UniProt: Q93063

Pathways: Glycosaminoglycan Metabolic Process